Navigation Links
World's First Cardiac Adult Stem Cell Trial to Take Place in Louisville
Date:2/11/2009

LOUISVILLE, Ky., Feb. 11 /PRNewswire-USNewswire/ -- The world's first phase one FDA-approved clinical trial using adult cardiac stem cells to treat heart disease will be conducted by a team of University of Louisville doctors at Jewish Hospital.

For the first time, patients with advanced heart disease who already are undergoing bypass surgery will be recruited for participation in the clinical trial, which uses adult stem cells taken from the patient's own cardiac tissue. During surgery, a small piece of tissue that is routinely removed during the bypass procedure will be frozen and sent to colleagues at Harvard University so that the adult cardiac stem cells can be extracted and removed.

After the patient has recovered for three to four months, the cells will be directly injected into cardiac scar tissue using a minimally-invasive cardiac catheterization procedure, which reaches the heart through a large artery in the patient's leg.

The patients will be evaluated over the course of at least a year for heart function and blood flow. The heart's overall size and the size of the scar tissue will be measured.

"Our hope is that the cardiac stem cells will help the heart tissue regenerate, reducing the size of the patient's scar tissue and improving heart function," said study leader Roberto Bolli, Jewish Hospital Heart and Lung Institute Distinguished Chair in Cardiology.

All patients enrolling in the clinical trial will receive the cardiac stem cell therapy, since this is a phase one clinical trial designed to test the treatment's safety and feasibility.

Bolli, who is also chief of the Division of Cardiology and director of UofL's Institute for Molecular Cardiology, is collaborating with a number of leaders in the field of cardiovascular and stem cell medicine for this clinical trial, including Piero Anversa, of Harvard University and Brigham & Women's Hospital in Boston and Mark Slaughter, Chief of the Division of Cardiothoracic Surgery at UofL.

Individuals wishing to learn more about this study should call 502-852-1387 or email cardiactrial@louisville.edu.


'/>"/>
SOURCE Jewish Hospital
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. HHS AIDS.gov to Use Blogs, Virtual Worlds, and Social Networks to Deliver HIV Information for World AIDS Day 2008
2. Gunther von Hagens BODY WORLDS Exhibitions Welcome Specimens From Worlds First Living Body Donor for Plastination
3. Gunther Von Hagens BODY WORLDS Exhibitions Mark 25th Million Visitor Milestone
4. California Science Center Welcomes 1-Millionth BODY WORLDS Visitor
5. Specimens in BODY WORLDS Exhibitions Stem Primarily from German Body Donation Program
6. The Institute for Plastination Responds to the Bishop of Manchesters Media Blitz, Assertions, and Allegations About BODY WORLDS Anatomical Exhibition Coming to Manchester
7. Museum Open Around the Clock - BODY WORLDS 2 and The Tech Host 40 Hour Marathon!
8. BODY WORLDS 3 & The Story of the Heart Opens at the California Science Center, March 14, 2008
9. BODY WORLDS 2 & Breathe California Pair Up for Some Ash Kicking
10. Solos Endoscopy, Inc. Posts First Nine Months Financials for 2008 on Pinksheets.com
11. Peregrine Pharmaceuticals Bavituximab Achieves Primary Endpoint in First Stage of Phase II Breast Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ORLEANS, La. (PRWEB) , ... July 21, 2017 ... ... to allow 4th-year medical students improve their chances of acceptance to a residency ... for those who have earned degrees outside the U.S. , According to data ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the ... from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related ... though activity levels decline over time. The study, presented today at the ...
(Date:7/20/2017)... ... July 20, 2017 , ... ChenMed , a ... joined JenCare Senior Medical Center as Richmond Chief Medical Officer. Dr. ... Medicine, and Associate Chief Medical Officer of Ambulatory Services for the UVA Health System, ...
(Date:7/20/2017)... ... July 20, 2017 , ... For individuals with extended hospital ... adjustable beds used in such facilities are specially designed to accommodate patients with a ... , An inventor from Rochester, Ind., has invented the patent-pending PORTABLE ARM REST, ...
(Date:7/20/2017)... MD (PRWEB) , ... July 20, 2017 , ... ... company dedicated to the development of non-invasive devices and systems for monitoring cardiopulmonary ... million. , Proceeds will be used to complete regulatory submissions and fund final ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... , July 10, 2017 Locus Biosciences Inc. ... to support the development of CRISPR-Cas3 antimicrobial therapeutics. Financing ... a leading Chinese Internet services provider, and joined by ... multiple infectious disease product programs targeting antibiotic resistant infections ... Founded by Dr. Rodolphe Barrangou and ...
(Date:7/5/2017)... a company of over 2,000 employees and a leader in environmental and life ... solidifying their position as the top American owned and operated environmental testing firm ... ... ... TN , enhances Pace Analytical,s capability as an innovative full service provider ...
(Date:6/30/2017)... , June 30, 2017  AVACEN Medical (AVACEN) announced the ... The research describes the use of its AVACEN Treatment Method ... suffering from fibromyalgia. ... AVACEN Medical ... characterized by chronic widespread pain. It affects approximately 200 to 400 million ...
Breaking Medicine Technology: